Citrullinated antibodies in systemic lupus erythematosus and primary Sjogren's syndrome

被引：0

作者：

Hullo, D. ^{[1
]}

Szoeke, L. ^{[2
]}

Szollosl, I ^{[3
]}

Balog, A. ^{[1
]}

Sonkodi, G. ^{[1
]}

Lele, K. ^{[1
]}

Torok, E. ^{[3
]}

Kovacs, L. ^{[1
]}

Zeher, M. ^{[3
]}

Sipka, S. ^{[3
]}

Pokorny, G. ^{[1
]}

机构：

[1] Univ Szeged, Dept Rheumatol, Szeged, Hungary

[2] Univ Szeged, Dept Clin Chem, Szeged, Hungary

[3] Univ Debrecen, Dept Internal Med 3, Debrecen, Hungary

来源：

2ND EUROPEAN CONGRESS OF IMMUNOLOGY (ECI) | 2009年

关键词：

EROSIVE ARTHRITIS; REVISED CRITERIA; PEPTIDE; CLASSIFICATION;

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Although anti-cyclic-citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) antibodies are highly sensitive scrological markers for the diagnosis of rheumatoid arthritis (RA). These antibodies can also occur in systemic lupus erythematosus (SLF) and in primary Sjogren's syndrome (SS). Of our 115 SLF patients. 21 (18.3%) were anti-MCV and 10(8.7%) anti-CCP positive. Of the 68 SS patients. 10 (14.7%) were anti-MCV and 7 (10.3%) anti-CCP positive. No correlation was observed between the antibody positivity and the organ manifestations. In the 139 RA control patients. anti-CCP positivity was more common (108/139) than anti-MCV positivity (92/139).

引用

页码：309 / +

页数：3

共 50 条

[21] Cytokine polymorphisms in systemic lupus erythematosus and Sjogren's syndrome
Magnusson, V
Nakken, B
Bolstad, AI
Alarcón-Riquelme, ME
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (1-2) : 55 - 61
[22] Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome
Ampélas, JF
Wattiaux, MJ
Van Amerongen, AP
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2001, 27 (06): : 588 - 599
[23] Pulmonary manifestations of systemic lupus erythematosus and Sjogren's syndrome
Velazquez, Marco Lopez
Highland, Kristin B.
CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (05) : 449 - 464
[24] SS-A/Ro antibodies in Chinese patients with systemic lupus erythematosus and Sjogren's syndrome
Tsay, GJ
Wang, CL
Chen, TY
Huang, CN
Hsu, TC
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1996, 95 (12) : 905 - 910
[25] Genetics of systemic lupus erythematosus and Sjogren's syndrome: an update
Teruel, Maria
Alarcon-Riquelme, Marta E.
CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (05) : 506 - 514
[26] Biologics in the treatment of Sjogren's syndrome, systemic lupus erythematosus, and lupus nephritis
Narain, Sonali
Berman, Nicola
Furie, Richard
CURRENT OPINION IN RHEUMATOLOGY, 2020, 32 (06) : 609 - 616
[27] SJOGREN SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS
ANDONOPOULOS, AP
SKOPOULI, FN
DIMOU, GS
DROSOS, AA
MOUTSOPOULOS, HM
JOURNAL OF RHEUMATOLOGY, 1990, 17 (02) : 201 - 204
[28] HLA DR-DQ haplotypes and genotypes in patients with systemic lupus erythematosus with co-existing Sjogren's syndrome, systemic lupus erythematosus without Sjogren's syndrome and primary Sjogren's syndrome: clinical and laboratory associations
Ch Georgopoulou
E Zintzaras
M Papadimitropoulos
M Spyropoulou
A Stavropoulou
HM Moutsopoulos
MN Manoussakis
Arthritis Research & Therapy, 7
[29] HLA DR-DQ haplotypes and genotypes in patients with systemic lupus erythematosus with co-existing Sjogren's syndrome, systemic lupus erythematosus without Sjogren's syndrome and primary Sjogren's syndrome: clinical and laboratory associations
Georgopoulou, Ch
Zintzaras, E.
Papadimitropouls, M.
Spyropoulou, M.
Stavropoulou, A.
Moutsopoulos, H. M.
Manoussakis, M. N.
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S38 - S38
[30] Can Extraglandular Manifestations Differentiate Primary Sjogren's Syndrome from Sjogren's-Systemic Lupus Erythematosus Overlap Syndrome?
Carsons, Steven E.
Movva, Suneel
Ienopoli, Sabatino
Aziz, Steven
Gul, Maryam
Calixte, Rose
Brodsky, Tracy
ARTHRITIS & RHEUMATOLOGY, 2015, 67

← 1 2 3 4 5 →